RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
Il33
interleukin 33
treatment
ISO
RGD
PMID:25912172
RGD:39939026
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
G
Cd274
CD274 molecule
treatment
ISO
RGD
PMID:30315719
RGD:41410787
NCBI chr 1:247,519,890...247,539,659
Ensembl chr 1:247,519,939...247,537,943
G
RT1-Bb
RT1 class II, locus Bb
disease_progression
ISO
DNA:polymorphism: :HLA-DQB1*02(human)
RGD
PMID:9756400
RGD:36174003
NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
G
RT1-Db1
RT1 class II, locus Db1
ISO
DNA:polymorphisms: :HLA-DRB1*03, DRB1*11(human)
RGD
PMID:9756400
RGD:36174003
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
G
Tlr2
toll-like receptor 2
ISO
mRNA:increased expression:PBMC
RGD
PMID:30141853
RGD:15090814
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
G
Il1rl1
interleukin 1 receptor-like 1
treatment
ISO
mRNA:increased expression:brain:
RGD
PMID:24657070 , PMID:23148283
RGD:11561855 , RGD:40400713
NCBI chr 9:47,133,483...47,184,316
Ensembl chr 9:47,134,034...47,182,170
G
Il33
interleukin 33
ISO
protein:increased expression:brain:
RGD
PMID:23148283 , PMID:24076431
RGD:40400713 , RGD:40400715
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
G
Il5
interleukin 5
ISO
RGD
PMID:8361777
RGD:11354948
NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
G
Mag
myelin-associated glycoprotein
disease_progression
ISO
RGD
PMID:20399564
RGD:27226693
NCBI chr 1:89,345,325...89,360,905
Ensembl chr 1:89,345,429...89,360,733
G
Mbp
myelin basic protein
disease_progression
ISO
RGD
PMID:20399564
RGD:27226693
NCBI chr18:79,326,738...79,437,310
Ensembl chr18:79,326,738...79,437,310
G
Mobp
myelin-associated oligodendrocyte basic protein
disease_progression
ISO
RGD
PMID:20399564
RGD:27226693
NCBI chr 8:128,824,420...128,854,492
Ensembl chr 8:128,824,508...128,850,358
G
Cd40
CD40 molecule
ISO
protein:increased expression:plasmacytoid dendritic cell
RGD
PMID:20702728
RGD:5490530
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
G
Muc2
mucin 2, oligomeric mucus/gel-forming
IEP
RGD
PMID:17187651
RGD:7349350
NCBI chr 1:214,663,929...214,693,197
G
Fas
Fas cell surface death receptor
IEP
mRNA, protein:increased expression:liver
RGD
PMID:18427836
RGD:2315733
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Faslg
Fas ligand
IEP
mRNA, protein:increased expression:liver
RGD
PMID:18427836
RGD:2315733
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
G
Il33
interleukin 33
ISO
mRNA,protein:increased expression:liver, serum: protein:increased expression:serum:
RGD
PMID:26944417 , PMID:26944417
RGD:39939001 , RGD:39939001
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
G
Tlr2
toll-like receptor 2
ISO
RGD
PMID:28784165
RGD:15090810
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
G
Il4
interleukin 4
treatment
ISO
RGD
PMID:25726962
RGD:14696685
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
G
RT1-Bb
RT1 class II, locus Bb
ISO
DNA:polymorphisms: :HLA- DQB1*0.9, DQB1*02(human)
RGD
PMID:22308705
RGD:36174019
NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
G
RT1-Db1
RT1 class II, locus Db1
ISO
DNA:polymorphism: :HLA-DRB1*03, DRB1*07(human)
RGD
PMID:22308705
RGD:36174019
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
G
Tlr2
toll-like receptor 2
disease_progression
ISO
DNA:mutation:cds:Arg753Gln(human) mRNA:increased expression:peripheral blood monocyte:
RGD
PMID:31437685 , PMID:21923667
RGD:15090825 , RGD:18182935
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
G
Tlr4
toll-like receptor 4
ISO
mRNA:increased expression:peripheral blood monocyte:
RGD
PMID:21923667
RGD:18182935
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
ISO
RGD
PMID:2142987
RGD:5128834
NCBI chr 3:4,374,679...4,394,374
Ensembl chr 3:4,374,602...4,394,428
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24270252
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
G
Hbb
hemoglobin subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24270252
NCBI chr 1:168,971,269...168,972,680
Ensembl chr 1:168,971,274...168,972,725
G
Il5
interleukin 5
ISO
mRNA: increased expression: : peritoneal lavage cells
RGD
PMID:21912714
RGD:5687176
NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24270252
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
G
Ctsb
cathepsin B
IEP
protein:decreased activity:liver (rat)
RGD
PMID:19696938
RGD:2315504
NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
G
Glud1
glutamate dehydrogenase 1
IEP
protein:increased expression:serum
RGD
PMID:10431747
RGD:6484593
NCBI chr16:10,661,486...10,695,557
Ensembl chr16:10,662,021...10,695,557
G
Il1rl1
interleukin 1 receptor-like 1
ISO
RGD
PMID:27592711
RGD:40400889
NCBI chr 9:47,133,483...47,184,316
Ensembl chr 9:47,134,034...47,182,170
G
Prg2
proteoglycan 2
ISO
RGD
PMID:24626328
RGD:40903014
NCBI chr 3:72,385,678...72,389,245
Ensembl chr 3:72,385,666...72,389,276
G
Cd274
CD274 molecule
ISO
mRNA, protein:increased expression:liver
RGD
PMID:25907244
RGD:41412175
NCBI chr 1:247,519,890...247,539,659
Ensembl chr 1:247,519,939...247,537,943
G
Igf2
insulin-like growth factor 2
ISO
protein:decreased expression:serum
RGD
PMID:12927688
RGD:5509967
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
G
Pdcd1
programmed cell death 1
ISO
mRNA, protein:increased expression:liver
RGD
PMID:25907244
RGD:41412175
NCBI chr 9:101,305,742...101,319,937
Ensembl chr 9:101,307,764...101,319,845
G
Cd209a
CD209a antigen
ISO
mRNA,protein:decreased expression:spleen,liver (mouse)
RGD
PMID:29386115 , PMID:24729611
RGD:39938990 , RGD:39938995
NCBI chr12:2,341,960...2,347,543
Ensembl chr12:2,341,960...2,347,543
G
Clec4m
C-type lectin domain family 4 member M
ISO
RGD
PMID:18981244
RGD:39938988
NCBI chr12:2,817,633...2,826,303
Ensembl chr12:2,816,065...2,826,378
G
Krt18
keratin 18
disease_progression
ISO
protein:increased expression:serum (mouse, human)
RGD
PMID:21357724
RGD:21406434
NCBI chr 7:143,629,455...143,633,131
Ensembl chr 7:143,629,455...143,633,131
G
Serpinf1
serpin family F member 1
ISO
RGD
PMID:9038736
RGD:30296660
NCBI chr10:62,241,750...62,254,145
Ensembl chr10:62,241,756...62,254,287
G
Il1rl1
interleukin 1 receptor-like 1
ISO
RGD
PMID:22329990
RGD:39938827
NCBI chr 9:47,133,483...47,184,316
Ensembl chr 9:47,134,034...47,182,170
G
Il33
interleukin 33
ISO
mRNA,protein:increased expression:Bronchoalveolar lavage, epithelium, macrophage
RGD
PMID:22329990
RGD:39938827
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
G
Tff2
trefoil factor 2
ISO
RGD
PMID:22329990
RGD:39938827
NCBI chr20:9,872,669...9,876,008
Ensembl chr20:9,872,680...9,876,008
G
Ifng
interferon gamma
ISO
RGD
PMID:29950724
RGD:14974257
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Nfkb1
nuclear factor kappa B subunit 1
disease_progression
ISO
RGD
PMID:12370384
RGD:40902988
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
G
Nfkb2
nuclear factor kappa B subunit 2
treatment
ISO
RGD
PMID:12370384
RGD:40902988
NCBI chr 1:266,050,634...266,059,277
Ensembl chr 1:266,053,002...266,059,256
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
protein:increased expression:liver (rat)
RGD
PMID:12621079
RGD:2306675
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Il1rl1
interleukin 1 receptor-like 1
severity
ISO
RGD
PMID:27697499
RGD:40400689
NCBI chr 9:47,133,483...47,184,316
Ensembl chr 9:47,134,034...47,182,170
G
Il33
interleukin 33
ISO
associated with Nippostrongylus brasiliensis infection; mRNA:increased expression:lung
RGD
PMID:22331917
RGD:40400742
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
G
Il4
interleukin 4
IEP
mRNA:increased expression:spleen
RGD
PMID:17570971
RGD:2317296
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
G
Muc13
mucin 13, cell surface associated
ISO
protein:increased expression:cecum, glycocalyx
RGD
PMID:21155842
RGD:7364766
NCBI chr11:70,185,757...70,223,012
Ensembl chr11:70,185,757...70,211,701
G
Muc2
mucin 2, oligomeric mucus/gel-forming
IEP ISO
mRNA:increased expression:intestine
RGD
PMID:16689826 , PMID:20138044
RGD:2303607 , RGD:7349349
NCBI chr 1:214,663,929...214,693,197
G
Muc3
mucin 3, intestinal
IEP
mRNA:increased expression:intestine
RGD
PMID:16689826
RGD:2303607
NCBI chr12:22,535,663...22,584,775
G
Muc4
mucin 4, cell surface associated
IEP ISO
mRNA:increased expression:intestine protein:increased expression:cecum, glycocalyx
RGD
PMID:16689826 , PMID:21155842
RGD:2303607 , RGD:7364766
NCBI chr11:71,242,973...71,285,217
Ensembl chr11:71,243,334...71,284,939
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
resistance
ISO IEP
mRNA:increased expression:cecum
RGD
PMID:20138044 , PMID:22269441
RGD:7349349 , RGD:7364747
NCBI chr 1:214,725,482...214,756,653
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
susceptibility
ISO
RGD
PMID:11850627
RGD:737789
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:20695884
RGD:5130965
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
G
Il13
interleukin 13
severity
ISO
protein:increased expression:serum
RGD
PMID:22805723
RGD:8549600
NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphisms: :HLA-DQA1*0401, HLA-DQA1*0102,HLA-DQA1*0103;
RGD
PMID:22117902
RGD:8547660
NCBI chr20:4,066,133...4,070,726
Ensembl chr20:4,066,132...4,070,721
G
RT1-Ha
RT1 class II, locus Ha
ISO
RGD
PMID:8854084
RGD:6480649
NCBI chr20:3,875,478...3,885,140
Ensembl chr20:3,875,706...3,881,461
G
Il1r1
interleukin 1 receptor type 1
ISO
RGD
PMID:19168746
RGD:8662882
NCBI chr 9:46,962,291...47,038,139
Ensembl chr 9:46,962,288...47,036,670
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:11884755
RGD:7794682
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
G
Actr3
actin related protein 3
ISO
RGD
PMID:25809205
RGD:11570559
NCBI chr13:41,695,520...41,738,622
Ensembl chr13:41,695,183...41,738,658
G
Mir192
microRNA 192
ISO
RNA:increased expression:urine
RGD
PMID:26456596
RGD:41404678
NCBI chr 1:221,634,971...221,635,080
Ensembl chr 1:221,634,971...221,635,080
G
Ager
advanced glycosylation end product-specific receptor
ISO
protein:decreased expression:lung (mouse)
RGD
PMID:23369670
RGD:7243187
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
G
Bud31
BUD31 homolog
IEP
Protein:increased expression:serum (human)
RGD
PMID:22686541
RGD:10058982
NCBI chr12:11,232,963...11,240,449
Ensembl chr12:11,232,964...11,240,400
G
Il33
interleukin 33
ISO
mRNA,protein:increased expression:liver
RGD
PMID:29554131
RGD:39938854
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
G
Prdx1
peroxiredoxin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19041905
NCBI chr 5:135,536,413...135,551,986
Ensembl chr 5:135,536,413...135,551,990
G
Rassf1
Ras association domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23527093
NCBI chr 8:116,307,149...116,318,289
Ensembl chr 8:116,307,141...116,318,289
G
RT1-Db1
RT1 class II, locus Db1
treatment
ISO
DNA:polymorphism: :HLA-DRB1*13
RGD
PMID:16709874
RGD:36049813
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
G
Sting1
stimulator of interferon response cGAMP interactor 1
ISO
RGD
PMID:32404867
RGD:39128195
NCBI chr18:28,529,537...28,535,828
Ensembl chr18:28,529,576...28,535,828
G
Timp3
TIMP metallopeptidase inhibitor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23527093
NCBI chr 7:23,543,125...23,594,170
Ensembl chr 7:23,544,215...23,594,133
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
G
Il33
interleukin 33
treatment severity
ISO
protein:increased expression:serum
RGD
PMID:22590860 , PMID:25944738 , PMID:25944738
RGD:39939027 , RGD:40400890 , RGD:40400890
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
G
Mir223
microRNA 223
treatment
ISO
RNA:increased expression:plasma:
RGD
PMID:24330517 , PMID:24330517
RGD:21408589 , RGD:21408589
NCBI chr X:65,367,812...65,367,921
Ensembl chr X:65,367,812...65,367,921
G
Pdcd1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733 , PMID:27792733 , PMID:27792733
RGD:40818413 , RGD:40818413 , RGD:40818413
NCBI chr 9:101,305,742...101,319,937
Ensembl chr 9:101,307,764...101,319,845
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:16042197
RGD:14398841
NCBI chr20:4,066,133...4,070,726
Ensembl chr20:4,066,132...4,070,721
G
Serpinh1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chr 1:164,301,010...164,308,306
Ensembl chr 1:164,301,010...164,308,317
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chr 8:77,640,234...77,719,488
Ensembl chr 8:77,640,222...77,719,489
G
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
G
Cd86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
G
Ihh
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chr 9:82,208,223...82,214,440
Ensembl chr 9:82,208,223...82,214,440
G
Il13
interleukin 13
treatment
IMP
RGD
PMID:10903803
RGD:8549615
NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
G
Tlr9
toll-like receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19797157
NCBI chr 8:114,916,122...114,920,171
Ensembl chr 8:114,916,122...114,920,171
G
Tslp
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361
G
Aicda
activation-induced cytidine deaminase
ISO
RGD
PMID:23630966
RGD:32716404
NCBI chr 4:155,359,909...155,371,104
Ensembl chr 4:155,359,921...155,369,671
G
Il3
interleukin 3
ISO
RGD
PMID:20500666
RGD:5686890
NCBI chr10:39,620,535...39,622,973
Ensembl chr10:39,620,563...39,622,973
G
Il33
interleukin 33
ISO
mRNA:increased expression:lung
RGD
PMID:22331917
RGD:40400742
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
G
Plau
plasminogen activator, urokinase
IMP
RGD
PMID:18022622
RGD:6484141
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:16129701
RGD:8655932
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
G
Il5
interleukin 5
severity
ISO
RGD
PMID:9824515
RGD:11354934
NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
G
Tslp
thymic stromal lymphopoietin
ISO
mRNA:increased expression:multiple (mouse)
RGD
PMID:24327787
RGD:38596353
NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361
G
Ccl11
C-C motif chemokine ligand 11
ISO
protein:increased expression:plasma, respiratory system fluid/secretion
RGD
PMID:16168564
RGD:7248410
NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
G
Il4
interleukin 4
treatment
ISO
RGD
PMID:26732352
RGD:11534298
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
G
Olig2
oligodendrocyte transcription factor 2
ISO
RGD
PMID:25773181
RGD:40902825
NCBI chr11:31,389,514...31,392,890
Ensembl chr11:31,389,514...31,392,890
G
Il10
interleukin 10
ISO
RGD
PMID:23465441
RGD:11049476
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Lta
lymphotoxin alpha
ISO
RGD
PMID:19564380
RGD:8548805
NCBI chr20:4,851,889...4,854,677
Ensembl chr20:4,852,496...4,854,677
G
Slc17a8
solute carrier family 17 member 8
IEP
protein:increased expression:dorsal horn of spinal cord, dorsal root ganglion
RGD
PMID:22160634
RGD:9999169
NCBI chr 7:30,215,231...30,274,993
Ensembl chr 7:30,216,104...30,274,984
G
Slc6a4
solute carrier family 6 member 4
ISO
protein:decreased expression:jejunum (mouse)
RGD
PMID:16336502
RGD:38676482
NCBI chr10:63,153,656...63,188,377
Ensembl chr10:63,153,651...63,176,463
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:19564380
RGD:8548805
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tslp
thymic stromal lymphopoietin
disease_progression
ISO
RGD
PMID:23024277
RGD:38596337
NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361
G
Foxp1
forkhead box P1
IEP
mRNA:increased expression:duodenum (rat)
RGD
PMID:21698235
RGD:11561920
NCBI chr 4:131,362,178...131,963,466
Ensembl chr 4:131,366,744...131,694,755
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864659
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864659
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
G
Tslp
thymic stromal lymphopoietin
susceptibility
ISO
RGD
PMID:19273626
RGD:38549593
NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNPs:multiple:Gabonese(human)
RGD
PMID:22288822
RGD:7204674
NCBI chr 9:67,699,397...67,706,068
Ensembl chr 9:67,699,379...67,706,065
G
Il5
interleukin 5
resistance
ISO
RGD
PMID:9697734
RGD:7241010
NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
G
Stat6
signal transducer and activator of transcription 6
severity
ISO
DNA:SNP:enhancer: (rs324013)
RGD
PMID:18273035
RGD:7243977
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all